Evidence map›Paper›PMID 37361603›Full record

ReviewFrontiers in oncology2023

Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations.

Shruti Rajesh Patel, Giselle Alexandra Suero-Abreu, Angela Ai, Maya K Ramachandran, Kelly Meza, Narjust Florez

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Cancer and cardiotoxicity in the transgender population.Archivos de cardiologia de Mexico · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Shruti Rajesh PatelDepartment of Medicine, Division of Oncology, Stanford University and Stanford Cancer Institute, Stanford, CA, United States.
Giselle Alexandra Suero-AbreuMassachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Angela AiOlive View-University of California, Los Angeles Medical Center, Los Angeles, CA, United States.
Maya K RamachandranDepartment of Medicine, Division of Oncology, Stanford University and Stanford Cancer Institute, Stanford, CA, United States.
Kelly MezaDana Farber Cancer Institute, Boston, MA, United States.
Narjust FlorezDana Farber Cancer Institute, Boston, MA, United States.
Dana-Farber Cancer Institute · USLos Angeles Medical Center · USMassachusetts General Hospital · USStanford Cancer InstituteStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that patients with cancer have a significantly higher cardiovascular mortality risk than the general population. Cardio-oncology has emerged to focus on these issues including risk reduction, detection, monitoring, and treatment of cardiovascular disease or complications in patients with cancer. The rapid advances in early detection and drug development in oncology, along with socioeconomic differences, racial inequities, lack of support, and barriers to accessing quality medical care, have created disparities in various marginalized populations. In this review, we will discuss the factors contributing to disparities in cardio-oncologic care in distinct populations, including Hispanic/Latinx, Black, Asian and Pacific Islander, indigenous populations, sex and gender minorities, and immigrants. Some factors that contribute to differences in outcomes in cardio-oncology include the prevalence of cancer screening rates, genetic cardiac/oncologic risk factors, cultural stressors, tobacco exposure rates, and physical inactivity. We will also discuss the barriers to cardio-oncologic care in these communities from the racial and socioeconomic context. Appropriate and timely cardiovascular and cancer care in minority groups is a critical component in addressing these disparities, and there need to be urgent efforts to address this widening gap.

Indexed as

cancercardiologycardiooncologycardiotoxicityequityoncology

Identifiers

PMID37361603
PMCPMC10289233
OpenAlexW4380083075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.